John Waddell - Experiences with the subclinical control of PCV2 - Presentation Transcript
FIELD EVALUATION OF INGELVAC CIRCOFLEX ® ON GROWTH PERFORMANCE OF PIGS IN A SUBCLINICAL PCVAD HERD John Waddell, DVM, MBA
Determine the impact of one-dose of Ingelvac CircoFLEX® on growth performance of pigs in a “subclinical” PCVAD population
Determine if population weight distribution can be affected by immunization against PCV2
Objectives
Source farm is PRRSV naïve with routine monitoring
600 weaned pigs ( 21 days of age) were tagged, weighed and randomized at weaning by weight and sex
300 vaccinates / 300 controls
Pigs were commingled within pens throughout the study
Individual body weights were taken at day 0 , day 35 , and day 119
Cull pigs were defined as weighing less than 180 lbs on day 119
Material and Method
Source farm is PRRSV naïve with routine monitoring
600 weaned pigs ( 21 days of age) were tagged, weighed and randomized at weaning by weight and sex
300 vaccinates / 300 controls
Pigs were commingled within pens throughout the study
Individual body weights were taken at day 0 , day 35 , and day 119
Cull pigs were defined as weighing less than 180 lbs on day 119
Material and Method
Source farm is PRRSV naïve with routine monitoring
600 weaned pigs ( 21 days of age) were tagged, weighed and randomized at weaning by weight and sex
300 vaccinates / 300 controls
Pigs were commingled within pens throughout the study
Individual body weights were taken at day 0 , day 35 , and day 119
Cull pigs were defined as weighing less than 180 lbs on day 119
Material and Method
Serology
Serology
93 randomly selected pigs
Controlled for treatment group and sex
Six serial blood collection throughout study
PCV2, PRRS, Salmonella, Lawsonia and Mycoplasma
Results
1 Cull rate based on animals weighing less than 180 lbs on d119 Mortality and cull rate (Fisher's Exact Test) Results Variable Vaccinates Controls P-value Mortality Rate (%) 3.01 3.86 0.22 Cull Rate¹ (%) 1.34 6.69 0.001
1 Probability of a greater F-statistic Least square means for performance data ab Within a row, means without a common superscript letter differ (Student's t, P≤ 0.05) Results Variable Vaccinates Controls P-Value¹ Day 0 weight (lbs) 16.17 16.17 0.97 Day 35 weight (lbs) 50.83 50.79 0.94 Day 119 weight (lbs) 227.25 a 220.86 b 0.0005 Day 0-35 ADG (lbs) 0.99 0.99 0.91 Day 36-119 ADG (lbs) 2.10 a 2.02 b <0.0001 Day 0-119 ADG (lbs) 1.77 a 1.72 b 0.0006 Day 0-119 wt gain (lbs) 210.71 a 204.38 b 0.0006
Results Coefficient of Variation (CV) = 10.64(Vaccinated); 12.93 (Non-Vaccinated)
PCV2 Quantitative PCR a a a b b b Log Titer Weeks Post-Vaccination
The one dose PCV2 vaccine significantly increased growth rate (weight gain and ADG) in a population of high health pigs which do not meet the case definition of (clinical) PCVAD.
Culling rate was significantly reduced by vaccination.
Consistent with a diagnosis of subclinical PCVAD, the mortality rate did not significantly differ and this was not a primary complaint of the producer.
Conclusions
The right shift of weights and narrowing of weight range distribution for the vaccinated group of pigs illustrates the biologic and implied economic benefit of immunization.
From the World Pork Expo Educational Seminar sessions sponsored by Boehringer Ingelheim Vetmedica, Inc. during the 2009 World Pork Expo in Des Moines, Iowa, USA. less
0 comments
Post a comment